Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Available axes
Side-by-side release fields
Each side retains its own unit and denominator. Entity evidence and containing-label observations do not imply a product score or a head-to-head efficacy finding.
Technology: undefined. Input traceability score: Not available in this release..
Axis 2 · evidence
A2: no applicable score. Evidence amount: Not yet queried in this release.; PubMed RCT records: undefined: Not yet queried in this release.; direction balance: The direction of the study results has not been extracted.
Axis 3 · measurement integrity
There is not enough information to score this axis. Repeatability and agreement between laboratories have not been established in the available data.. Repeatability: undefined: no observation in this release; interlab: undefined: no observation in this release; independent validation: undefined: no observation in this release.
Axis 4 · observed review panel
200 observed documents or mentions; service share 44.0%; outcome-bearing share 12.0%; burst signal 0.0%.
Preference-dependent summary and price
GIS: no aggregate entity score. Price: undefined: no observation in this release. undefined: no open-data price observation in this release Observed: undefined: observation date unavailable.
Technology: metatranscriptomics (RNA sequencing of stool). Input traceability score: Not available in this release..
Axis 2 · evidence
A2: no applicable score. Evidence amount: 0.00; PubMed RCT records: 0; direction balance: The direction of the study results has not been extracted.
Axis 3 · measurement integrity
There is not enough information to score this axis. Repeatability and agreement between laboratories have not been established in the available data.. Repeatability: undefined: no observation in this release; interlab: undefined: no observation in this release; independent validation: undefined: no observation in this release.
Axis 4 · observed review panel
undefined: no review panel matched this side.
Preference-dependent summary and price
GIS: no aggregate entity score. Price: 199. vendor site (orchestrator note; verify at build) Observed: 2026-09-07.
Ivitskiy, I. (2026). ZOE vs Viome Gut Intelligence. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/vs/zoe-test-vs-viome-gut-intelligence/
ZOE has 0 of 3 integrity components available, compared with 0 of 3 for Viome Gut Intelligence; missing values mean insufficient open validation fields. Window: NIH DSLD snapshot Sep 2026.
ZOE: Not yet queried in this release. Viome Gut Intelligence: No indexed strain-level randomized human trial report was found in this ledger version (as of 2026-09-07).
Not yet queried in this release. / Not available in this release. PubMed records in the union of both compared entries · NIH DSLD snapshot Sep 2026 · comparison.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f732437
1 of 2 compared entries have a numeric price: ZOE, No numeric price observation is available in this release.; Viome Gut Intelligence, USD 199, vendor site (orchestrator note; verify at build), observed 2026-09-07. Window: NIH DSLD snapshot Sep 2026.